W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 6: 21st Century Cures Act. H.R. 4292: Synchronization & Nonadherence Correction (SYNC) Act of 2015. Education about the value of innovative new medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors. March 2016 CMS proposed rule implementing a new Part B drug payment model.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.